Skip to main content

Advertisement

Log in

Expression of Aβ42, τ-Protein, p16, p53 in Buccal Epithelium: Prospects for Use in the Diagnostics of Alzheimer’s Disease and Rate of Aging

  • BIOGERONTOLOGY
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

The expression of Aβ42, and τ-protein, and p16 and p53 proteins was analyzed in the buccal epithelium of elderly and senile patients with Alzheimer’s disease. We revealed enhanced synthesis of Alzheimer’s disease markers Aβ42 (by 15-30 times) and τ-protein (by 5 times) in comparison with the corresponding values in people without neurodegenerative pathology of the same age groups. In addition, increased synthesis of proteins of cell aging and apoptosis p16 (by 6-10 times) and p53 (by 2-3 times) was observed in patients in comparison with age-matched persons without neuropathology. These data suggest that complex analysis of the expression of Aβ42, τ-protein, p16, and p53 in the buccal epithelium is a promising method for in vivo diagnosis of Alzheimer’s disease and assessment of the rate of aging during the development of this pathology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ankarcrona M, Winblad B, Monteiro C, Fearns C, Powers ET, Johansson J, Westermark GT, Presto J, Ericzon BG, Kelly JW. Current and future treatment of amyloid diseases. J. Intern. Med. 2016;280(2):177-202.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Armstrong RA. A critical analysis of the ‘amyloid cascade hypothesis’. Folia Neuropathol. 2014;52(3):211-225.

    Article  CAS  PubMed  Google Scholar 

  3. Forero DA, González-Giraldo Y, López-Quintero C, Castro-Vega LJ, Barreto GE, Perry G. Meta-analysis of telomere length in Alzheimer’s disease. J. Gerontol. A Biol. Sci. Med. Sci. 2016;71(8):1069-1073.

    Article  PubMed  PubMed Central  Google Scholar 

  4. François M, Fenech MF, Thomas P, Hor M, Rembach A, Martins RN, Rainey-Smith SR, Masters CL, Ames D, Rowe CC, Macaulay SL, Hill AF, Leifert WR, The Australian Imaging Biomarkers and Lifestyle Study Research Group. High content, multi-parameter analyses in buccal cells to identify Alzheimer’s disease. Curr. Alzheimer Res. 2016;13(7):787-799.

    Article  CAS  PubMed  Google Scholar 

  5. François M, Leifert W, Martins R, Thomas P, Fenech M. Biomarkers of Alzheimer’s disease risk in peripheral tissues; focus on buccal cells. Curr. Alzheimer Res. 2014;11(6):519-531.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Garcia A, Mathur S, Kalaw MC, McAvoy E, Anderson J, Luedke A, Itorralba J, Mai S. Quantitative 3D telomeric imaging of buccal cells reveals Alzheimer’s disease-specific signatures. J. Alzheimers Dis. 2017;58(1):139-145.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Hartmann S, Möbius HJ. Tolerability of memantine in combination with cholinesterase inhibitors in dementia therapy. Int. Clin. Psychopharmacol. 2003;18(2):81-85.

    Article  PubMed  Google Scholar 

  8. Hattori H, Matsumoto M, Iwai K, Tsuchiya H, Miyauchi E, Takasaki M, Kamino K, Munehira J, Kimura Y, Kawanishi K, Hoshino T, Murai H, Ogata H, Maruyama H, Yoshida H. The tau protein of oral epithelium increases in Alzheimer’s disease. J. Gerontol. A Biol. Sci. Med. Sci. 2002;57(1):M64-M70.

    Article  PubMed  Google Scholar 

  9. Khan TK, Sen A, Hongpaisan J. PKCε deficits in Alzheimer’s disease brains and skin fibroblasts. J. Alzheimers Dis. 2015;43(2):491-509.

    Article  CAS  PubMed  Google Scholar 

  10. Lovat LB, Persey MR, Madhoo S, Pepys MB, Hawkins PN. The liver in systemic amyloidosis: insights from 123I serum amyloid P component scintigraphy in 484 patients. Gut. 1998;42(5):727-734.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Micheli F, Palermo R, Talora C, Ferretti E, Vacca A, Napolitano M. Regulation of proapoptotic proteins Bak1 and p53 by miR-125b in an experimental model of Alzheimer’s disease: Protective role of 17β-estradiol. Neurosci. Lett. 2016;629:234-240.

    Article  CAS  PubMed  Google Scholar 

  12. O’Brien RJ, Wong PC. Amyloid precursor protein processing and Alzheimer’s disease. Annu. Rev. Neurosci. 2011;34:185-204.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Sajan FD, Martiniuk F, Marcus DL, Frey WH, Hite R, Bordayo EZ, Freedman ML. Apoptotic gene expression in Alzheimer’s disease hippocampal tissue. Am. J. Alzheimers Dis. Other Demen. 2007;22(4):319-328.

    Article  PubMed  Google Scholar 

  14. Schott K, Wormstall H, Dietrich M, Klein R, Batra A. Autoantibody reactivity in serum of patients with Alzheimer’s disease and other age-related dementias. Psychiatry. 1996;59(3):251-254.

    CAS  Google Scholar 

  15. Thomas P, Hecker J, Faunt J, Fenech M. Buccal micronucleus cytome biomarkers may be associated with Alzheimer’s disease. Mutagenesis. 2007;22(6):371-379.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N. S. Lin’kova.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 166, No. 11, pp. 627-631, November, 2018

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zuev, V.A., Dyatlova, A.S., Lin’kova, N.S. et al. Expression of Aβ42, τ-Protein, p16, p53 in Buccal Epithelium: Prospects for Use in the Diagnostics of Alzheimer’s Disease and Rate of Aging. Bull Exp Biol Med 166, 676–679 (2019). https://doi.org/10.1007/s10517-019-04416-0

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-019-04416-0

Key Words

Navigation